SCHEMBL25540221

SCHEMBL25540221

CC1(C)c2cccc(-c3ccc(-c4ccc(-c5nc(-c6ccccc6)cc(-c6cccc(-c7ccccc7)c6)n5)c5ccccc45)c4ccccc34)c2-c2c1ccc1ccccc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.33
MAPT P10636 5/20 0.33
KDM4E B2RXH2 4/20 0.33
HPGD P15428 4/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
LMNA P02545 2/20 0.33
PIM1 P11309 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
DNMT1 P26358 1/20 0.32
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
TSHR P16473 2/20 0.32
ATM Q13315 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
TP53 P04637 1/20 0.32
NFKB1 P19838 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25538973 1.00 ALDH1A1 (0.33) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL25538978 0.99 CYP1A1 (0.34) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL25540400 0.99 CYP1A1 (0.34) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL25539083 0.98 CA12 (0.34) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL25539011 0.96 MAPT (0.33) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL25540396 0.96 CYP1A1 (0.34) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL25538976 0.96 CYP1A1 (0.34) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL25540224 0.96 CYP1A1 (0.34) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL25538968 0.96 MAPT (0.35) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL25540223 0.96 MAPT (0.35) ALDH1A1MAPTKDM4EHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM ALDH1A1 254/4885MAPT 1595/4885KDM4E 1565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.